Vantage logo

Clearside’s future clouds over

After failing in retinal vein occlusion, the prospects for the eye project Xipere – and Clearside Biomedical itself – hinge on the smaller uveitis indication.

Vantage logo
Independent, data-driven daily news and analysis on pharma, biotech and medtech.